Kyle Mikson

Stock Analyst at Canaccord Genuity

(3.03)
# 1,272
Out of 5,129 analysts
121
Total ratings
41.94%
Success rate
1.54%
Average return

Stocks Rated by Kyle Mikson

Illumina
Jan 26, 2026
Maintains: Hold
Price Target: $130$150
Current: $119.32
Upside: +25.71%
GeneDx Holdings
Dec 22, 2025
Maintains: Buy
Price Target: $160$170
Current: $94.78
Upside: +79.36%
10x Genomics
Dec 22, 2025
Maintains: Buy
Price Target: $19$20
Current: $19.15
Upside: +4.44%
Tempus AI
Dec 22, 2025
Maintains: Buy
Price Target: $95$80
Current: $55.88
Upside: +43.16%
Quanterix
Dec 22, 2025
Maintains: Hold
Price Target: $5$8
Current: $6.12
Upside: +30.72%
Quantum-Si incorporated
Dec 22, 2025
Maintains: Hold
Price Target: $2$1.5
Current: $1.10
Upside: +36.36%
Natera
Dec 22, 2025
Maintains: Buy
Price Target: $250$285
Current: $211.65
Upside: +34.66%
Guardant Health
Dec 22, 2025
Maintains: Buy
Price Target: $100$125
Current: $105.03
Upside: +19.01%
Castle Biosciences
Dec 22, 2025
Maintains: Buy
Price Target: $37$50
Current: $32.37
Upside: +54.46%
Caris Life Sciences
Dec 22, 2025
Maintains: Hold
Price Target: $28$30
Current: $22.17
Upside: +35.32%
Downgrades: Hold
Price Target: $85$105
Current: $103.35
Upside: +1.60%
Maintains: Buy
Price Target: $85$105
Current: $103.68
Upside: +1.27%
Maintains: Hold
Price Target: $40$43
Current: $37.03
Upside: +16.12%
Maintains: Hold
Price Target: $150$165
Current: $143.06
Upside: +15.34%
Maintains: Buy
Price Target: $11$15
Current: $3.50
Upside: +328.57%
Maintains: Buy
Price Target: $30$20
Current: $10.40
Upside: +92.31%
Maintains: Buy
Price Target: $3
Current: $1.81
Upside: +65.75%
Maintains: Buy
Price Target: $3
Current: $1.21
Upside: +147.93%
Maintains: Overweight
Price Target: $3$2
Current: $0.25
Upside: +716.33%
Initiates: Overweight
Price Target: $1,476
Current: $10.96
Upside: +13,367.15%